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a  b  s  t  r  a  c  t
Ricin,  a highly  toxic  plant-derived  toxin,  is  considered  a potential  weapon  in  biological
warfare  due  to  its  high  availability  and  ease  of  preparation.  Pulmonary  exposure  to ricin
results  in  the  generation  of an acute  edematous  inﬂammation  followed  by respiratory  insuf-
ﬁciency  and  death.  Passive  immunization  with  polyclonal  anti-ricin  antibodies  conferred
protection  against  pulmonary  ricinosis,  however,  at clinically-relevant  time  points  for  treat-
ment, survival  rates  were  limited.  In this  study,  intranasal  instillation  of  a lethal  dose  of
ricin  to mice,  served  as  a lung  challenge  model  for  the evaluation  and  comparison  of dif-
ferent therapeutic  modalities  against  pulmonary  ricinosis.  We  show  that treatment  with
doxycycline  resulted  in  a signiﬁcant  reduction  of  pro-inﬂammatory  cytokines,  markers  of
oxidative stress  and  capillary  permeability  in the  lungs  of the  mice.  Moreover,  survival
rates  of  mice  intoxicated  with  ricin  and  treated  24  h  later  with  anti-ricin  antibody  were  sig-
niﬁcantly improved  by  co-administration  of  doxycycline.  In contrast,  co-administration  of
the steroid  drug  dexamethasone  with  anti-ricin  antibodies  did  not  increase  survival  rates
when administered  at late hours  after  intoxication,  however  dexamethasone  did exert  a
positive effect  on survival  when  applied  in  conjunction  with  the doxycycline  treatment.
These  studies  strongly  suggest  that  combined  therapy,  comprised  of  neutralizing  anti-ricin
antibodies  and  an  appropriate  anti-inﬂammatory  agent,  can promote  high-level  protection
against  pulmonary  ricinosis  at clinically-relevant  time  points  post-exposure.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
the CC  BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).Abbreviations: BALF, bronchoalveolar lavage ﬂuid; ChE,
cholinesterase; MMP-9, matrix-metalloproteinase-9; PBS, phosphate-
buffered saline; sPLA2, secretory phospholipase A2; RCA, ricinus communis
agglutinin; VEGF, vascular endothelial growth factor; XO, xanthine
oxidase.
∗ Corresponding author. +972 89381522.
E-mail address: chanochk@iibr.gov.il (C. Kronman).
http://dx.doi.org/10.1016/j.toxrep.2014.07.013
2214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open a
licenses/by-nc-sa/3.0/).1. Introduction
Ricin, a toxin derived from the plant Ricinus commu-
nis, is an N-glycosidase that irreversibly inactivates the
28S  rRNA of the mammalian 60S ribosome subunit, sub-
sequently arresting cell protein synthesis [1]. The toxicity
of  ricin depends on the route of exposure, inhalatory expo-
sure  being considered most dangerous, the estimated dose
causing  death to 50% of the population (LD50) being within
the  range of several microgram/kilogram [2]. Pathological
studies of pulmonary ricin intoxication have demonstrated
ccess article under the CC BY-NC-SA license (http://creativecommons.org/
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hat injury is mostly conﬁned to the lungs [3]. The dam-
ge  inﬂicted to the lungs is manifested by perivascular,
nterstitial and alveolar edema, inﬂux of neutrophils to the
ungs  and the mounting of an acute inﬂammatory response.
looding of the lungs leads to respiratory insufﬁciency and
eath  [3].
Prophylactic anti-ricin vaccines have been developed
nd are now in human phase I studies [4], however,
ost-exposure medical countermeasures are needed for
reatment  of victims after pulmonary exposure to lethal
oses  of the toxin. Previous studies have examined
he possibility to protect animal models against pul-
onary ricinosis by passive immunization with polyclonal
nti-ricin antibodies. Protection levels declined with the
assage  of time after intoxication, and when the anti-ricin
ntibodies were administered 24 h after exposure, sur-
ival  rates were within the 30–50% range [5,6]. At this
ate  time point, the pathophysiological state of some of the
ntoxicated  mice may  have deteriorated so that the loss
f  function of the lungs is irreversible. Conversely, it may
e  that higher survival rates can be attained even at this
ate  time point if the raging pulmonary inﬂammation is
ssuaged  through additional medical intervention.
A growing body of studies supports the notion that
ntibiotic tetracyclines, restrain inﬂammatory responses of
arious  etiologies. Doxycycline, a tetracycline derivative,
as  been shown to inhibit staphylococcal exotoxin-
nduced production of cytokines and chemokines by
eripheral blood mononuclear cells [7] and to atten-
ate polymorphonuclear cell recruitment in models of
ung  injury secondary to LPS, bleomycin or Streptococcus
neumoniae pneumonia [8–10]. Recently, it was reported
hat  doxycycline exhibits anti-inﬂammatory activity in CF
ronchial  epithelial cells by inhibiting ERK 1/2, P38 and JNK
ependent cell signaling (Bensman et al., 2012). Interest-
ngly, signaling pathways involving ERK, P38 and JNK were
hown  in the past to be stimulated by ricin [11].
In the present study, we examined the possibility to
mprove survival of mice exposed intranasally to a lethal
ose  of ricin, by co-administration of doxycycline together
ith  polyclonal anti-ricin antibodies. Survival rates of mice
ubjected  to this combination treatment were compared
o  those attained by co-administration of the highly potent
nti-inﬂammatory steroid, dexamethasone, with the anti-
icin  antibodies. We  demonstrate that co-administration
f doxycycline together with anti-ricin antibodies signif-
cantly  improved the ability to protect mice even when
reatment with the drug commenced at late hours (24 h
ost-intoxication), while dexamethasone confers slightly
mproved survival only when administered early after
xposure. Nevertheless, dexamethasone did exert some
ositive effect on survival when administered late after
ntoxication in conjunction with both doxycycline and anti-
icin  antibodies.
.  Methods.1. Ricin preparation
Crude  ricin was prepared from seeds of endemic R.
ommunis, essentially as described before [12]. Brieﬂy,ts 1 (2014) 496–504 497
seeds  were homogenized in a Waring blender in 5% acetic
acid/phosphate buffer (Na2HPO4, pH 7.4) the homogenate
was centrifuged and the clariﬁed supernatant containing
the toxin was subjected to ammonium sulphate precipi-
tation (60% saturation). The precipitate was  dissolved in
phosphate-buffered saline (PBS) and dialyzed extensively
against the same buffer. The toxin preparation appeared
on  a Coomassie blue stained non-reducing 10% poly-
acrylamide gel as 2 major bands of molecular weight
approximately 65 kDa (= ricin toxin, ∼80%) and 120 kDa
(=R.  communis agglutinin (RCA), ∼20%). Protein concentra-
tion was determined as 2.86 mg/ml  by 280 nm absorption
(Nanodrop). Pure toxin was prepared as described pre-
viously [12,13]. Brieﬂy, the crude ricin preparation was
loaded  onto a gel-ﬁltration column (Superdex 200HR 16/60
Hiload  16/600 superdex 200 pg on an AKTA explorer,
GE Healthcare Bio-Science AB; Uppsala; Sweden) and
washed out with PBS to yield two well-separated pro-
tein  peaks corresponding to RCA and ricin. The purity of
the  ricin fraction was  estimated by SDS-PAGE analysis to
be  >98%.
2.2. Anti-ricin antibodies
Rabbits  were immunized with pure ricin toxin with Fre-
und’s  adjuvant in a stepwise manner, injections 1, 2 and
3  containing 4, 16 and 16 g toxin/rabbit respectively and
subsequent injections containing 100 g toxin/rabbit, with
4-week  intervals between injections. Blood samples were
collected (1 week after injection) to ascertain anti-ricin
antibody titer build-up. Immunization was  continued until
steady  high anti-ricin titers were observed.
Anti-ricin antibody titers were determined by ELISA.
Microtiter plates (Nunc) were coated with pure ricin
(2.5 ng/ml in carbonate buffer pH 9.6, overnight incu-
bation at room temperature), washed 3 times in wash
buffer (0.8%NaCl + 0.05% Tween-20) and then incubated
with blocking buffer (PBS + 0.05% Tween 20 + 2% BSA) for 1 h
at  37 ◦C. Rabbit antisera samples were added in 2-fold serial
dilutions and incubated at 37 ◦C for 1 h. Plates were then
washed 3 times with wash buffer and incubated at 37 ◦C for
1  h with AP-conjugated goat anti-rabbit immunoglobulin
(Sigma, 1:500 in blocking buffer). After washing as above,
the  microtiter plates were developed with substrate (p-
NPP,  Sigma) and optical densities were measured at 405 nm
using  an ELISA reader (Molecular Devices).
Concentrated anti-ricin IgG preparations were gener-
ated from pooled hyperimmune antisera by precipitation
of the proteins with ammonium sulfate (40% saturation,
overnight with constant stirring). Following centrifuga-
tion (5000 rpm, 50 min, 4 ◦C), the pellet was  dissolved
in puriﬁed water, and subjected to dialysis (overnight,
30 mM phosphate buffer pH = 7.4). The dialyzed proteins
were applied on an anion-exchange column (Express-Ion,
exchanger D; Whatman) and eluted with 60 mM phosphate
buffer containing 1 M NaCl. The sample was precipitated
by the addition of ammonium sulfate (40%, 3 h), and fol-
lowing  centrifugation (5000 rpm, 60 min, 4 ◦C) the pellet
was  dissolved in 300 mM  glycine buffer (pH = 7.4) and
dialyzed (300 mM  glycine buffer pH = 7.4 overnight). The
gy Repor498 Y. Gal et al. / Toxicolo
concentrated anti-ricin antibody preparations were stored
at  4 ◦C until used in in vivo experiments.
2.3.  Animal studies
Animal  experiments were performed in accordance
with the Israeli law and were approved by the Ethics
Committee for Animal Experiments at the Israel Insti-
tute  for Biological Research. Treatment of animals was in
accordance with regulations outlined in the USDA Animal
Welfare Act and the conditions speciﬁed in the Guide for
Care  and Use of Laboratory Animals (National Institute of
Health,  1996).
All  animals in this study were female CD-1 mice (Charles
River Laboratories Ltd., UK) weighing 27–32 g. Prior to
exposure, animals were habituated to the experimental
animal unit for 5 days. All mice were housed in ﬁlter-top
cages in an environmentally controlled room and main-
tained at 21 ± 2 ◦C and 55 ± 10% humidity. Lighting was set
to  mimic  a 12/12 h dawn to dusk cycle. Animals had access
to  food and water ad libitum.
For  intoxication, mice were anesthetized by an
intraperitoneal injection of ketamine (1.9 mg/mouse) and
xylazine  (0.19 mg/mouse). Crude ricin (50 l; 7 g/kg
diluted in PBS) was applied intranasally (2× 25 l)
and mortality was monitored over 14 days. Preced-
ing these studies, we determined that 3.5 g crude
ricin/kg body weight is approximately equivalent to one
mouse  (intranasal) LD50 (95% conﬁdence intervals of
2.3–4.5 g/kg body weight).
Treatments were performed on mice anesthetized as
above.  For antibody treatment, a volume of 50 l of anti-
ricin  antibody preparation was delivered intranasally (2×
25  l), intramuscularly or intravenously at various time
points following intoxication. Doxycycline-hyclate (Sigma)
was  dissolved in PBS and administered (200 l) intraperi-
toneally at 24, 48, 72 and 96 h post-exposure, at doses
of  100, 100, 50 and 25 mg/kg body weight, respectively.
Dexamethasone 21-phosphate disodium salt (Sigma) was
administered intranasally at a dose of 4 mg/kg body weight.
2.4.  Bronchoalveolar lavage ﬂuid (BALF) preparation and
analysis
BALF,  collected by instillation of 1 ml  PBS at room tem-
perature, was centrifuged at 1500 rpm at 4 ◦C for 10 min.
Supernatants were collected and stored at −20 ◦C until
further use. The levels of IL-6, IL-1, TNF-, and vascu-
lar endothelial growth factor (VEGF) were determined by
ELISA  using commercial kits purchased from R&D Systems.
Levels of secretory phospholipase A2 (sPLA2) and (xanthine
oxidase) XO in BALF were determined by activity assay
kits  purchased from Assay Designs and Molecular Probes,
respectively.
Cholinesterase (ChE) enzymatic activity was measured
according to Ellman [14]. Assays were performed in
the  presence of 0.5 mM acetylthiocholine, 50 mM sodium
phosphate buffer pH 8.0, 0.1 mg/ml  BSA and 0.3 mM 5,5′-
dithiobis-(2-nitrobenzoic acid). The assay was carried out
at  27 ◦C and monitored by a Thermomax microplate reader
(Molecular Devices).ts 1 (2014) 496–504
Matrix-metalloproteinase (MMP)  activity in BALF sam-
ples  was determined by zymography. BALF samples were
electrophoresed on 10% SDS-PAGE gels co-polymerized
with gelatin (10% Ready Gel® zymogram gel, Biorad). SDS
was  expelled by 30 min  incubation with 2.5% Triton X-
100,  and gels were incubated with developing solution
(50 mM Tris, 0.2 M NaCl, 5 mM CaCl2, and 0.02% (w/v) Brij®
35 (Sigma) (pH 7.6)) over night. Gels were then stained
for  30 min  with 0.5% Coomassie G250 (Bio-Rad, Israel)
in  methanol:acetic acid:water (30:10:60) and destained
in  tap water for 24 h. Relative densities of MMP-9 were
analyzed with Bio-Rad Quantity One software (Bio-Rad,
Hercules, CA, USA). Results were compared to a positive
standard and expressed as mean ± SEM.
2.5.  Statistical analysis
Animal  survival experimental data was obtained by
pooling results of three or more independent experiments,
each with 8–10 mice per experiment group. Compari-
son of the Kaplan–Meier survival curves of mice in each
individual experiment using the log-rank (Mantel–Cox)
test showed that there are no statistically signiﬁcant dif-
ferences  among groups of animals receiving the same
treatment in independent experiments. No discrepancies
in treatment effects from experiment to experiment were
noted.  In other experiments, individual groups were com-
pared  using unpaired t test analysis. To estimate p values, all
statistical  analyses were interpreted in a two-tailed man-
ner.  Values of p < 0.05 were considered to be statistically
signiﬁcant. All data is presented as means ± S.E.M.
3. Results
Pulmonary exposure to ricin results in the generation of
a  severe localized edematous inﬂammation which eventu-
ally  leads to respiratory insufﬁciency and death [2]. The
lack  of antidotes against pulmonary ricinosis, prompted
us to examine the prospect to alleviate intoxication by
post-exposure combined therapy, comprising anti-ricin
antibodies and a drug. In the present study, intranasal
instillation served as a lung challenge model for the evalu-
ation  and comparison of different therapeutic modalities.
3.1.  Treatment with anti-ricin antibodies
To determine the therapeutic window for protection
against pulmonary exposure to ricin by antibodies, a
lethal  dose of ricin (7 g/kg body weight) was instilled
intranasally to groups of mice and at various time points
prior  or following intoxication, mice were intranasally
administered a ﬁxed volume (50 l) of anti-ricin antiserum
prepared at our laboratory from hyperimmune rabbits.
Mice were monitored for survival for 14 days following
exposure.
Administration of anti-ricin antibodies by the intranasal
route 24 h before exposure, or a short period of time (3 h)
after  exposure, conferred protection to 100 and >90% of
the  mice, respectively. Treatment with antibodies at later
time  points resulted in descending levels of protection; 75,
53  and 34% of the mice survived when antibodies were
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Fig. 1. Therapeutic window for post-exposure treatment of ricin-
intoxicated mice with anti-ricin antibodies. Mice were intoxicated
intranasally with ricin (7 g/kg body weight) and treated with anti-ricin
antibodies at the indicated time points. Animals were observed for a
2-week period after ricin challenge. Curves with different letters are sig-
niﬁcantly different (p < 0.05). Number of animals per experimental group:
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Table 1
Survival of ricin-intoxicated mice following combined treatment with
anti-ricin antibodies and dexamethasone. Survival of mice lethally
challenged with ricin (7g/kg), and treated with anti-ricin antibodies
(intranasal, 2× 25l) at 24 h PE and/or dexamethasone (4 mg/kg body
weight) at the indicated time points.
Time of treatment (h PE) % Survival
Anti-ricin antibodies Dexamethasone
– 0, 24 3a
24  – 34b
24 −8, 24 82c
24 6, 24 44b
3.3. Pro-inﬂammatory markers in the lung4  h, 6 h PE: n = 25; 3 h PE: n = 15; 18 h PE: n = 30; 24 h PE: n = 29; untreated:
 = 74.
dministered 6, 18 and 24 h after intoxication, respectively
Fig. 1). In contrast, intramuscular administration of the
ame  anti-ricin antiserum preparation at 3 h after intoxica-
ion  resulted in low-level protection only (20%), while none
f  the mice survived when anti-ricin antibodies were deliv-
red  intramuscularly 18–24 h after intoxication. In fact,
reatment via the i.m. route resulted in poor survival (33%)
ven  when antibody administration preceded intoxication.
hese ﬁndings indicate that effective protection depends
n  the introduction to the lungs of sufﬁcient amounts of
nti-ricin antibodies within the period of time relevant for
rotection,  a requirement met  by the topical administra-
ion to the lungs by intranasal application. It is interesting
o  note, that intravenous administration of the anti-ricin
ntibodies at 6 or 24 h post-exposure conferred protection
imilar to that observed for intranasal administration of the
ntibodies  (data not shown).
In  these protection experiments, we used antiserum
ollected from hyperimmune rabbits vaccinated against
icin.  To determine whether the antibody dose in these
xperiments limits survival levels, mice intranasally
xposed to a lethal dose of ricin were treated 24 h post-
ntoxication side-by-side either with the antiserum or with
gG-enriched preparations derived from this antiserum,
he latter exhibiting higher anti-ricin titers in ELISA. Pro-
ection  levels following treatment with concentrated IgG
reparations exhibiting anti-ricin titers that are 8- or 16-
old  higher (5 × 106 and 107) than that of the antiserum
6.4 × 105) were not signiﬁcantly higher than the pro-
ection level conferred by the antiserum (42% and 45%
rotection, respectively, as opposed to 39% protection with
ntiserum). The rather similar survival rate values exhib-
ted  following treatment with different dosages of antibody
ndicate that the upper limit of protection by treatment
ith antibodies has been reached and that survival values
annot be further improved in a signiﬁcant manner, merely
y  increasing the dose of antibodies.24 24 30b
Represent groups displaying signiﬁcant statistic difference (a, b, c).
3.2. Effect of dexamethasone on the survival of mice
Pulmonary exposure to ricin causes a severe localized
inﬂammation which is accompanied by a massive recruit-
ment  of neutrophils to the lungs (Lindauer et al., 2009(.
High levels of protein were found in the BALF sampled from
the  inﬂamed lungs ([6] and our results, not shown), indicat-
ing  that the lung–blood barrier has been disrupted. Since
steroids are known both to suppress neutrophil migration
and  to mitigate capillary permeability [15], we examined
the  effect of dexamethasone, a potent steroid drug, on the
survival  rates of mice that were intranasally exposed to a
lethal  dose of ricin.
Administration of dexamethasone in conjunction with
the  24 h PE anti-ricin antibody treatment, exerted a
signiﬁcant positive effect on survival of mice intranasally-
exposed to a lethal dose of ricin only when the steroid
was ﬁrst administered prior to intoxication (8 h before
intoxication) (Table 1). When dexamethasone treatment
commenced at an early time point after intoxication (6 h
PE),  the increase in protection was  considerably lower,
while administration of the steroid at 24 h PE, concomitant
with the antibody treatment, did not lead to any noticeable
improvement in survival.
Steroids  operate mostly at the transcriptional level,
exerting their anti-inﬂammatory effects by respectively
promoting and repressing the expression of genes encoding
for  anti- and pro-inﬂammatory elements [16]. If transcrip-
tion  of pro-inﬂammatory factors occurs rapidly following
ricin  exposure, the effectiveness of steroid compounds
such as dexamethasone are expected to be compromised
when applied late after exposure. Conversely, compounds
that interact directly with pro-inﬂammatory proteins may
be  more efﬁcient in their ability to subdue inﬂammation
at clinically-relevant time points. In an effort to tailor a
treatment against pulmonary ricinosis, which includes a
drug  that is effective even when administered late after
intoxication, we  scrutinized the progressing lung patho-
physiology following intranasal exposure of mice to ricin,
for  mediators of inﬂammation which can serve as targets
for  post-exposure drug therapy.Elevated levels of the pro-inﬂammatory cytokines TNF-
,  IL-1 and IL-6 were measured in BALF samples collected
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Fig. 2. Pro-inﬂammatory cytokines in the BALF of ricin intoxicated mice.
Mice were intranasally exposed to 7 g/kg ricin and BALF samples col-
Fig. 3. Markers of vascular permeability in the BALF of ricin-intoxicated
crobial activity, has been also shown to possess diverselected at the indicated time points were monitored for: A. IL-1 (squares),
TNF- (triangles), B. IL-6. Data are mean ± S.E.M. N = 5.
from mice at various time points following intranasal ricin
intoxication. Peak levels of TNF- were reached at 24 h PE,
after  which there was a moderate decrease during the next
48  h (Fig. 2A). IL-1 levels also rose during the 24 h fol-
lowing intoxication, yet unlike TNF-, remained elevated
during the next 48 h (Fig. 2A). Cytokine levels of IL-6 in
BALF  rose rapidly, displaying a signiﬁcant 12-fold increase
as  soon as 6 h PE (Fig. 2B). IL-6 levels continued to rise, dis-
playing  a 24-, 45- and >50-fold increase above control, at
24,  48 and 72 h PE, respectively.
Vascular endothelial growth factor (VEGF) promotes
vascular permeability and interstitial edema [17] and
therefore we determined VEGF levels in the BALF samples
collected from these ricin-intoxicated mice. Indeed, 24 h
post-ricin  intoxication, VEGF increased signiﬁcantly, there-
after,  remaining unchanged for the following 48 h (Fig. 3A).
In  line with this ﬁnding, signiﬁcantly increased levels of the
serum-resident enzyme cholinesterase, were found in the
BALF  of intoxicated mice, albeit at a later stage (Fig. 3B),
attesting to the fact that the blood–lung barrier has been
severely impaired.
Next,  we sought to examine in the BALF of ricin-
intoxicated mice, markers associated with oxidative stress,
lipolysis  and proteolysis. Xanthine oxidase (XO), an enzyme
associated with oxidative damage, increased only slightlymice. Mice were intranasally exposed to 7 g/kg ricin and BALF samples
collected at the indicated time points were monitored for: (A) VEGF, (B)
ChE.  Data are mean ± S.E.M. N = 5.
(2-fold over control levels) during the ﬁrst 48 h after intox-
ication, however, during the next 24 h levels of this enzyme
accelerated, displaying an overall 20-fold increase (Fig. 4A).
Expression  of XO results in localized formation of reac-
tive  oxygen species that correlate with the degree of lung
pathologies [18] and contributes to lung injury [19]. Lev-
els  of the lipolytic enzyme secretory phospholipase A2
(sPLA2), a potent mediator of inﬂammation responsible for
hydrolysis  of surfactant phospholipids [20], rose signiﬁ-
cantly after ricin-intoxication displaying a 44-fold increase
during  the 72 h period following intoxication (Fig. 4B). Lev-
els  of the gelatinolytic enzyme matrix-metalloproteinase-9
(MMP-9) ascended rapidly after ricin-intoxication, display-
ing  a peak level equivalent to >100-fold increase already at
24  h PE. (Fig. 4C). MMP-9 plays an important role in lung
injuries [21] and correlate with alveolar-capillary perme-
ability  [22].
3.4.  Doxycycline treatment reduces signs of
ricin-induced pulmonary inﬂammation
Doxycycline, a compound well-known for its antimi-anti-inﬂammatory capabilities. These include down reg-
ulation  of proinﬂammatory cytokines [7], anti-oxidant
activity [23], inhibition of matrix-metalloproteinases [9]
Y. Gal et al. / Toxicology Repor
Fig. 4. Oxidative, lipolytic and proteolytic pro-inﬂammatory parameters
in the BALF of ricin-intoxicated mice. Mice were intranasally exposed to
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e g/kg ricin and BALF samples collected at the indicated time points were
onitored for: (A) xanthine oxidase (XO), (B) secretory phospholipase A2
sPLA2), (C) matrix-metalloproteinase-9 (MMP-9). Data are mean ± S.E.M.
 = 5.
nd sPLA2 [24], and mitigation of vascular hyperperme-
bility [25]. Since, as detailed above, these inﬂammation-
elated characteristics were observed following pulmonary
xposure to ricin, we decided to examine the effect of
oxycycline treatment in itself on these inﬂammation-
elated elements in the lungs of ricin-intoxicated mice.
o  this end, mice intranasally exposed to a lethal dose
f  ricin were administered doxycycline only (100 mg/kg
ody  weight, immediately after intoxication and then
00,  50 and 25 mg/kg body weight at 24, 48 and 69 h
ost-intoxication, respectively), lungs were lavaged at
2  h PE and BALF was subjected to analysis. Doxycycline
xerted an anti-inﬂammatory effect on the majority ofts 1 (2014) 496–504 501
the  inﬂammation-related parameters examined (Fig. 5A).
Levels  of the proinﬂammatory cytokines IL-1 and IL-6
were  considerably lower in mice treated with doxycycline.
Likewise, XO was substantially reduced in the doxycycline-
administered mice, as compared to ricin-intoxicated mice
that  were not treated. Capillary permeability was  also
attenuated in these mice, as judged by the reduced levels of
VEGF  and ChE (Fig. 5A), the latter being a serum-resident
protein whose incongruous presence in the lumen of the
lungs  is indicative of lung–blood barrier disruption. In con-
trast,  administration of doxycycline did not affect BALF
levels  of MMP-9 (Fig. 5B), which remained as high as
in  intoxicated mice that were not treated with doxycy-
cline. A positive effect of doxycycline on MMP-9 levels
was  however exhibited when mice were administered both
doxycycline and antibodies shortly after intoxication, while
mice  that received antibodies only did not exhibit reduc-
tion  in this marker (Fig. 5B).
Overall, treatment with doxycycline led to reduced
pulmonary edema, as witnessed by the weight reduc-
tion of mice lungs following doxycycline administration
(Fig. 5C). Nevertheless, treatment with doxycycline in itself
conferred  no more than marginal protection to the ricin
intoxicated mice; approximately 90% of the mice died
without displaying an increase in mean time to death
values. We  therefore examined the effect of doxycycline
administration on mice survival, in conjunction with the
antibody-based treatment.
3.5.  Effect of doxycycline on the survival of mice
Mice were intranasally exposed to a lethal dose of
ricin and 24 h later were subjected to combined anti-
ricin antibodies and doxycycline treatment. Indeed, adding
doxycycline to the antibody treatment improved survival
rates,  which reached 58%, nearly 2-fold higher compared
to  mice treated with antibodies only (34% survival) (Fig. 6).
As  mentioned above, adding dexamethasone failed to
improve  protection when administered at late hours with
anti-ricin  antibodies, nevertheless, when dexamethasone
was applied as an adjunct to the doxycycline/anti-ricin
antibody treatment, survival rates seem to be further
elevated (74% protection, Fig. 6). Taken together, these
ﬁndings demonstrate that anti-inﬂammatory drugs exert
a  positive effect on mice survival, when applied as add-
ons  to the post-exposure antibody-based therapy against
pulmonary ricinosis.
4.  Discussion
In the present study, we  demonstrate that the survival
rates of mice treated with anti-ricin antibodies at rela-
tively late hours (24 h) post-pulmonary intoxication can
be  considerably improved by co-administration of doxy-
cycline. The improved survival displayed in mice treated
with  doxycycline stems from the anti-inﬂammatory prop-
erties  of this compound; doxycycline promotes signiﬁcant
reduction of pro-inﬂammatory cytokines and markers of
oxidative  stress and capillary permeability in the lungs
of  the intoxicated mice. Various studies have shown that
doxycycline exerts its anti-inﬂammatory effects not only
502 Y. Gal et al. / Toxicology Reports 1 (2014) 496–504
Fig. 5. Pathological and pro-inﬂammatory changes in the BALF of ricin intoxicated mice following treatment with -ricin antibodies or with -ricin
antibodies  and doxycycline. Mice were intranasally exposed to 7 g/kg ricin and subjected to different treatment modes. (A) Ricin-intoxicated mice were
treated  with doxycycline immediately after intoxication and BALF collected at 72 h was monitored for IL-1, IL-6, VEGF, ChE and XO. (B) Ricin-intoxicated
LF colle
hed. W
parison mice  were treated with doxycycline and/or anti-ricin antibodies and BA
treated  with doxycycline and lungs were harvested at 72 h PE and weig
represent  the standard error of the mean of the samples. *p < 0.05 in com
at the transcriptional level by down-regulation of pro-
inﬂammatory cytokines [7,16], but also by interacting with
pro-inﬂammatory mediators, or compromising their abil-
ity  to operate. Thus, doxycycline has been shown to: (a) act
as  an anti-oxidant agent by reacting with free radicals [23],
(b)  serve as a chelator of zinc/calcium ions, thereby inhib-
iting  MMPs  [26], (c) prevent vascular hyperpermeability
by inducing expression of VE-cadherin on endothelial cells
[25],  and (d) inhibit sPLA2 via direct interaction with this
enzyme [27].
Although administration of doxycycline had a marked
beneﬁcial effect on inﬂammation-related markers, doxy-
cycline  in itself provided no more than marginal (10%) pro-
tection  to mice that were intranasally exposed to a lethal
dose  of ricin. It seems that ricin by virtue of being highly
inﬂammogenic, persistently stimulates acute inﬂamma-
tory responses with which doxycycline alone cannot cope.
Anti-ricin  antibody treatment is therefore required to halt
any  further pro-inﬂammatory ﬁring, whilst doxycycline
exerts its positive effect by dampening inﬂammation that
has  already developed. Indeed, though treatment with
doxycycline alone reduced inﬂammation-related factors tocted at 72 h was  monitored for MMP-9. (C) Ricin-intoxicated mice were
et  lung weight is presented as percent of total body weight. Error bars
to non-treated mice. N = 5.
a  considerable extent, values remained higher than in con-
trol  mice (see Fig. 5). Alternatively, doxycycline treatment
in  itself may  not sufﬁce for protection, since anti-ricin anti-
bodies  are required for curbing inﬂammation-independent
ricin-induced cytotoxicity caused by protein synthesis
arrest. The inter-relationship between protein synthesis
arrest and the clinical manifestation of pulmonary ricinosis,
namely, the onset of a severe edematous inﬂammation
accompanied by massive recruitment of neutrophils and
cytokine  storming, has yet not been resolved. It may  well
be  that large scale disruption of ribosomes (= quantitative
protein synthesis arrest) is not required for establish-
ment of full-blown pulmonary ricinosis. A “minimal” role
for  protein synthesis arrest in pulmonary ricinosis, would
maintain that low-key ricin-induced cessation of protein
synthesis is sufﬁcient as a trigger for launching full-scale
inﬂammation. Previous studies suggested that termina-
tion of protein synthesis, or perhaps the actual damage
to  ribosomes by ricin, initiates a MAPKinase-driven proin-
ﬂammatory signaling cascade termed “ribotoxic stress
response”, whereby cytokines such as TNF- and IL1-
  are upregulated [11,28]. In another study, it was
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Fig. 6. Kaplan–Meier survival curves of mice intoxicated with ricin and
subjected to post-exposure treatment. Mice were intoxicated intranasally
with ricin (7 g/kg) and subjected to various treatments as indicated. Ani-
mals  were observed for a 2-week period after ricin challenge. The various
treatments were commenced at 24 h post exposure and included -ricin
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[ntibodies (Ab), doxycycline (dox), or dexamethasone (dex), or their com-
inations, as indicated within the ﬁgure (n = 29–31). Curves corresponding
o the “untreated” and “Ab” groups are those displayed in Fig. 1.
uggested that termination of cellular protein synthesis
y ricin initiates inﬂammation by allowing turnover of
abile  suppressor proteins that under normal conditions
revent the conversion of inactive pro-IL1- into biolog-
cally active proinﬂammatory IL1- [29]. A recent study
emonstrated that sessile alveolar macrophages and pul-
onary  epithelial cells, mutually suppress cytokine release
30].  It may  well be that ricin-inﬂicted injury to alve-
lar macrophages, an early event following pulmonary
ntoxication [31], prompts the onset of pro-inﬂammatory
esponses by de-repressing cytokine synthesis by the
pithelial cells. Conversely, in a model which assumes a
maximal” role for protein synthesis arrest in pulmonary
icinosis, ricin-mediated intoxication leads to large-scale
ibosome damage, which in turn, gives rise to a protein
ynthesis arrest-related disease which is life-threatening in
tself,  regardless of inﬂammation. The scope and magnitude
f  the ricin-induced disease that develops in the absence of
nﬂammation, has not been determined. Regardless of the
xact  model, our study amply demonstrates that inﬂam-
ation plays a decisive role in pulmonary ricin toxicity and
hat  alleviation of inﬂammation contributes signiﬁcantly to
urvival.
Unlike  the combined doxycycline/anti-ricin antibody
reatment, dexamethasone improved survival rates only if
he  steroid was applied before or shortly after intoxication,
ut not when it was administered simultaneously with
he  antibody treatment, 24 h post-exposure. Nevertheless,
examethasone did exert some positive effect when co-
dministered at 24 h after ricin intoxication together with
oth  the anti-ricin antibodies and doxycycline. Survival
ates following this tripartite treatment were higher than
hen  only doxycycline was added to the antibody treat-
ent  (74% survival after dexamethasone/doxycycline/Ab
reatment, 58% survival after doxycycline/Ab treatment,
 = 0.07). In what way does the dexamethasone improve
urvival in this unique therapeutic set-up, in terms of
he  underlying anti-inﬂammatory reactions, remains to be
eciphered.
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In  summary, we show that compounds displaying mul-
tifaceted anti-inﬂammatory traits, such as doxycycline, can
bestow  improved protection following pulmonary ricin-
intoxication even when administered at clinically-relevant
time points. Judicious choice of other anti-inﬂammatory
agents for treatment, based on in-depth knowledge of
pulmonary ricinosis pathology should lead to further
improvement in medical treatment, as well as providing
valuable tools for unraveling the intricate cascades and
pathways underlying ricin intoxication.
Transparency document
The  Transparency document associated with this article
can be found in the online version.
Acknowledgments
We thank Dr. Arik Makovitzki and Mr.  Avi Agami for the
production of the concentrated anti-ricin IgG preparations.
References
[1] S. Olsnes, J.V. Kozlov, Ricin, Toxicon 39 (2001) 1723–1728.
[2] J. Audi, M.  Belson, M.  Patel, J. Schier, J. Osterloh, Ricin poisoning: a
comprehensive review, JAMA 294 (2005) 2342–2351.
[3]  C.L. Wilhelmsen, M.L.M. Pitt, Lesions of acute inhaled lethal ricin
intoxication in rhesus monkeys, Vet. Pathol. 33 (1996) 296–302.
[4] J.M. O’Hara, R.N. Brey, N.J. Mantis, Comparative efﬁcacy of two lead-
ing  candidate ricin toxin a subunit vaccines in mice, Clin. Vaccine
Immunol. 20 (2013) 789–794.
[5] J.L. Holley, S.J.C. Poole, I.A.M. Cooper, G.D. Grifﬁths, A.J. Simpson, The
production and evaluation of ricin antitoxins, in: Defence against
the  Effects of Chemical Hazards: Toxicology, Diagnosis and Medical
Countermeasures, Meeting Proceedings RTO-MP-HFM-149, Paper
12,  Neuilly-sur-Seine, France, 2007, pp. 12-1–12-8, Available from
http://www.rto.nato.int
[6]  T.S. Pratt, S.H. Pincus, M.L. Hale, A.L. Moriera, C.J. Roy, K.M.
Tchou-Wong, Oropharyngeal aspiration of ricin as a lung challenge
model for evaluation of the therapeutic index of antibodies against
ricin  A-chain for post-exposure treatment, Exp. Lung Res. 33 (2007)
459–481.
[7]  T. Krakauer, M. Buckley, Doxycycline is anti-Inﬂammatory
and inhibits staphylococcal exotoxin-induced cytokines and
chemokines, Antimicrob. Agents Chemother. 47 (2003) 3630–3633.
[8] M.  Fujita, Q. Ye, H. Ouchi, E. Harada, I. Inoshima, K. Kuwano,
Y. Nakanishi, Doxycycline attenuated pulmonary ﬁbrosis induced
by  bleomycin in mice, Antimicrob. Agents Chemother. 50 (2006)
739–743.
[9]  M.  Fujita, E. Harada, S. Ikegame, Q. Ye, H. Ouchi, I. Inoshima, Y. Nakan-
ishi,  Doxycycline attenuated lung injury by its biological effect apart
from  its antimicrobial function, Pulm. Pharmacol. Ther. 20 (2007)
669–675.
10]  A. Moon, S. Gil, S.E. Gill, P. Chen, G. Matute-Bello, Doxycycline impairs
neutrophil migration to the airspaces of the lung in mice exposed to
intratracheal lipopolysaccharide, J. Inﬂamm. 9 (2012) 31–35.
11] V. Korcheva, J. Wong, C. Corless, M.  Iordanov, B. Magun, Admin-
istration of ricin induces a severe inﬂammatory response via
nonredundant stimulation of ERK, JNK and P38 MAPK and provides
a  mouse model of hemolytic uremic syndrome, Am.  J. Pathol. 166
(2005)  323–339.
12] J.Y. Lin, S.Y. Liu, Studies on the antitumor lectins isolated from the
seeds  of Ricinus Communis (Castor bean), Toxicon 24 (1986) 757–765.
13] G.D. Grifﬁths, C.D. Lindsay, D.G. Upshall, Examination of the toxic-
ity  of several protein toxins of plant origin using bovine pulmonary
endothelial cells, Toxicology 90 (1994) 11–27.
14]  G.L. Ellman, K.D. Courtney, V. Andres, R.M. Featherstone, A new and
rapid  colorimetric determination of acetylcholinesterase activity,
Biochem. Pharmacol. 7 (1961) 88–95.
15]  N. Ohta, M.  Shimaoka, H. Imanaka, M.  Nishimura, N. Taenaka, H. Kiy-
ono,  I. Yoshiya, Glucocorticoid suppresses neutrophil activation in
ventilator-induced lung injury, Crit. Care Med. 29 (2001) 1012–1016.
gy Repor
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
Cohen, A.S. Prince, J. Bhattacharya, Sessile alveolar macrophages504 Y. Gal et al. / Toxicolo
16] N. Singh, M.J. Rieder, M.J. Tucker, Mechanisms of glucocortico-
mediated anti-inﬂammatory and immunosuppressive action, Pae-
diatr.  Perinat. Drug Ther. 6 (2004) 107–115.
17]  R.J. Kaner, J.V. Ladetto, R. Singh, N. Fukuda, M.A. Matthay, R.G. Crystal,
Lung  overexpression of the vascular endothelial growth factor gene
induces  pulmonary edema, Am.  J. Cell. Mol. Biol. 22 (2000) 657–664.
18] Y. Komaki, H. Sugiura, A. Koarai, M.  Tomaki, H. Ogawa, T. Akita, T. Hat-
tori,  M.  Ichinose, Cytokine-mediated xanthine oxidase upregulation
in chronic obstructive pulmonary disease’s airways, Pulm. Pharma-
col.  Ther. 18 (2005) 297–302.
19] R.M. Wright, L.A. Ginger, N. Kosila, N.D. Elkins, B. Essary, J.L. McMana-
man,  J.E. Repine, Mononuclear phagocyte xanthine oxireductase
contributes to cytokine-induced acute lung injury, Am.  J. Respir. Cell
Mol.  Biol. 30 (2004) 479–490.
20] L. Touqui, L. Arbibe, A role for phospholipase A2 in ARDS pathogene-
sis, Mol. Med. Today 5 (1999) 244–249.
21]  D.E. Carney, U.G. McMann, H.J. Schiller, L.A. Gatto, J. Steinberg, A.L.
Picone,  G.F. Nieman, Metalloproteinase inhibition prevents acute
respiratory distress syndrome, J. Surg. Res. 99 (2001) 245–252.
22] P.M. Soccal, Y. Gasche, J.C. Pache, O. Schneuwly, D.O. Slosman, D.R.
Morel,  A. Spiliopoulos, P.M. Suter, L.P. Nicod, Matrix metallopro-
teinases correlate with alveolar-capillary permeability alteration
in  lung ischemia-reperfusion injury, Transplantation 70 (2000)
998–1005.
23]  H. Akamatsu, M.  Asada, J. Komura, Y. Asada, Y. Niwa, Effect of doxy-
cycline on the generation of reactive oxygen species: a possible
mechanism of action of acne therapy with doxycycline, Acta. Derm.
Venereol. 72 (1992) 178–179.
[ts 1 (2014) 496–504
24]  W.  Pruzanski, R.A. Greenwald, I.P. Street, F. Laliberte, E. Stefan-
ski, P. Vadas, Inhibition of enzymatic activity of phospholipase A2
by minocycline and doxycycline, Biochem. Pharmacol. 44 (1992)
1165–1170.
25]  O. Fainaru, I. Adini, O. Benny, L. Bazinet, E. Pravda, R. D’Amato, J. Folk-
man,  Doxycycline induces membrane expression of VE-cadherin on
endothelial  cells and prevents vascular hyperpermeability, FASEB J.
22  (2008) 3728–3735.
26] L.M. Golub, H.M. Lee, M.E. Ryan, W.V. Giannobile, J. Payne, T.
Sorsa, Tetracyclines inhibit connective tissue breakdown by mul-
tiple  non-antimicrobial mechanisms, Adv. Dent. Res. 12 (1998)
12–26.
27]  D. Dalm, G.J. Palm, A. Aleksandrov, T. Simonson, W.  Hinrichs, Nonan-
tibiotic properties of tetracyclines: structural basis for inhibition of
phospholipase A2, J. Mol. Biol. 398 (2010) 83–96.
28] V. Korcheva, J. Wong, M.  Lindauer, D.B. Jacoby, M.  Iordanov, B. Magun,
Role  of apoptotic signaling pathways in regulation of inﬂammatory
responses to ricin in primary murine macrophages, Mol. Immunol.
44  (2007) 2761–2771.
29] M.  Lindauer, J. Wong, B. Magun, Ricin toxin activates the NALP3
inﬂammasome, Toxins 2 (2010) 1500–1514.
30]  K. Westphalen, G.A. Gusarova, M.N. Islam, M.  Subramanian, T.S.communicate with alveolar epithelium to modulate immunity,
Nature 506 (2014) 503–506.
31] R.F.R. Brown, D.E. White, Ultrastructure of rat lung following inhala-
tion  of ricin aerosol, Int. J. Exp. Pathol. 78 (1997) 267–276.
